NCT01610427View on ClinicalTrials.gov

Study to Optimize the Quality of Samples for Cell-mediated Immunity (CMI) in ART-naïve HIV-1-infected Subjects

NACompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

June 25, 2012

Primary Completion Date

October 30, 2012

Study Completion Date

October 30, 2012

Conditions
AIDSAIDS Vaccines
Interventions
PROCEDURE

Blood sample collection

Blood samples will be collected in all subjects at two time points, at the Screening Visit (Day 0) and at the Sample Collection Visit (Day 15)

Trial Locations (1)

9000

GSK Investigational Site, Ghent

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY